The US company Barr Pharmaceuticals is set to acquire a 72.67% stake in the leading Croatian pharmaceutical producer, Pliva, having deposited more than 13.5m Pliva shares with the central depository agency in Zagreb on October 10th.
Američka kompanija Barr Pharmaceuticals spremna je preuzeti 72,67 posto dionica vodećeg hrvatskog farmaceutskog proizvođača, Plive, deponirajući 10. listopada dionice Plive u iznosu preko 13,5 milijuna eura u središnju depozitnu agenciju u Zagrebu.